<div id="readability-page-1"><p>Vontobel Holding Ltd. decreased its stake in  Celestica, Inc. (NYSE:CLS - Free Report) <span>TSE: CLS<span></span></span> by 80.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,759 shares of the technology company's stock after selling 7,429 shares during the quarter. Vontobel Holding Ltd.'s holdings in Celestica were worth $433,000 as of its most recent filing with the Securities and Exchange Commission.</p><ul><li>3 Stocks Poised to Benefit From Google’s AI Breakthough</li></ul><p>Other institutional investors also recently modified their holdings of the company. DAVENPORT &amp; Co LLC raised its position in shares of  Celestica by 8.6% in the 3rd quarter. DAVENPORT &amp; Co LLC now owns 9,051 shares of the technology company's stock valued at $2,228,000 after acquiring an additional 718 shares during the period.  Revisor Wealth Management LLC bought a new stake in  Celestica in the third quarter valued at approximately $265,000.  Munro Partners raised its holdings in  Celestica by 108.0% in the third quarter. Munro Partners now owns 51,695 shares of the technology company's stock worth $12,737,000 after purchasing an additional 26,840 shares during the period.  Farther Finance Advisors LLC boosted its position in shares of  Celestica by 95.7% during the third quarter. Farther Finance Advisors LLC now owns 4,888 shares of the technology company's stock worth $1,204,000 after purchasing an additional 2,390 shares in the last quarter.  Finally, S.E.E.D. Planning Group LLC acquired a new position in shares of  Celestica in the 3rd quarter valued at $205,000. 67.38% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Insider Buying and Selling</h2><p>In other Celestica news, Director Laurette T. Koellner bought 6,000 shares of the firm's stock in a transaction that occurred on Thursday, October 30th. The stock was acquired at an average price of $341.67 per share, with a total value of $2,050,020.00. Following the completion of the transaction, the director owned 6,000 shares in the company, valued at approximately $2,050,020. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Insiders own  0.52% of the company's stock. </p><h2>Celestica Stock Down 0.0%</h2><ul><li>This mid-cap tech stock just jumped 30%...and is still cheap</li></ul><p>NYSE:CLS opened at $303.45 on Tuesday. The stock has a 50-day simple moving average of $315.20 and a 200 day simple moving average of $241.44. Celestica, Inc. has a 52-week low of $58.05 and a 52-week high of $363.40. The company has a market cap of $34.91 billion, a PE ratio of 49.26 and a beta of 1.83. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.88 and a current ratio of 1.47. </p><p>Celestica (NYSE:CLS - Get Free Report) <span>TSE: CLS<span></span></span> last released its earnings results on Monday, October 27th. The technology company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.45 by $0.13. The firm had revenue of $3.19 billion for the quarter, compared to analysts' expectations of $3.01 billion. Celestica had a return on equity of 30.53% and a net margin of 6.35%.The business's quarterly revenue was up 27.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.04 EPS.  On average, sell-side analysts expect that  Celestica, Inc. will post 4.35 EPS for the current fiscal year. </p><h2>Wall Street Analyst Weigh In</h2><ul><li>3 bullish mid-cap earnings plays for January 2024</li></ul><p>Several analysts recently commented on the company. JPMorgan Chase &amp; Co. raised their price objective on Celestica from $295.00 to $360.00 and gave the stock an &#34;overweight&#34; rating in a research note on Wednesday, October 29th. Stifel Nicolaus  restated a &#34;buy&#34; rating and issued a $385.00 price target (up from $230.00) on shares of Celestica in a report on Wednesday, October 29th. TD Securities lifted their price objective on Celestica from $238.00 to $305.00 and gave the company a &#34;hold&#34; rating in a report on Wednesday, October 29th. Royal Bank Of Canada increased their target price on Celestica from $315.00 to $400.00 and gave the stock an &#34;outperform&#34; rating in a research note on Wednesday, October 29th. Finally, Citigroup upgraded shares of Celestica from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and raised their target price for the stock from $212.00 to $375.00 in a report on Monday, November 10th. One analyst  has rated the stock with a Strong Buy rating, thirteen have issued  a Buy rating and three have issued  a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and an average target price of $336.13.</p><p><b>Get Our Latest Stock Analysis on CLS</b></p><h2>About Celestica</h2> (Free Report)<p>Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.  </p><p>The company's service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Celestica</li><li>Wall Street Stockpicker Names #1 Stock of 2026</li><li>Do not delete, read immediately</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>Your “birthright claim” just got activated</li><li>Turn your &#34;dead money&#34; into $306+ monthly (starting this month)</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNMUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNMUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Celestica Right Now?</h2><p>Before you consider Celestica, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.</p><p>While Celestica currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Vontobel Holding Ltd. has significantly reduced its stake in Celestica, Inc. by 80.9%, selling 7,429 shares during the 3rd quarter, leaving it with 1,759 shares valued at $433,000. Other institutional investors have also adjusted their holdings, with notable increases from DAVENPORT & Co LLC and Munro Partners. Celestica's stock has shown volatility, with a recent earnings report exceeding expectations, and analysts have raised their price targets, reflecting a generally positive outlook for the company.</p>

Vontobel Holding Ltd. Sells 7,429 Shares of Celestica, Inc. $CLS